Blinatumomab Drug Interactions
Currently displaying a list of 273 drugs known to interact with blinatumomab.
- 63 major drug interactions
- 187 moderate drug interactions
- 23 minor drug interactions
Medications known to interact with blinatumomab
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- alfentanil
- allogeneic processed thymus tissue
- amifampridine
- aminophylline
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atezolizumab
- avelumab
- azathioprine
B
- baricitinib
- bcg
- bcg vaccine
- bedaquiline
- belimumab
- bifidobacterium infantis
- bifidobacterium longum
- black cohosh
- brentuximab
- brewer's yeast
- bupropion
C
- calaspargase pegol
- canakinumab
- candida albicans extract
- cannabidiol
- carbamazepine
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- cholera vaccine, live
- cinoxacin
- ciprofloxacin
- cladribine
- clofarabine
- clozapine
- coccidioidin skin test
- colchicine
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- cyclosporine
D
- daclizumab
- deferiprone
- delafloxacin
- dengue vaccine
- denosumab
- deucravacitinib
- dicumarol
- dimethyl fumarate
- diroximel fumarate
- disopyramide
- dostarlimab
- durvalumab
- dyphylline
E
- echinacea
- efalizumab
- efavirenz
- efbemalenograstim alfa
- efgartigimod alfa
- eflapegrastim
- elderberry
- enoxacin
- epirubicin
- etanercept
- etranacogene dezaparvovec
- etrasimod
- evening primrose
- everolimus
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydrocodone
I
- idelalisib
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- interferon beta-1a
- interferon beta-1b
- iohexol
- iomeprol
- iopamidol
- ipilimumab
- isoniazid
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- levofloxacin
- levoketoconazole
- lindane topical
- lomefloxacin
- lomitapide
- loncastuximab tesirine
- lyme disease vaccine
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- methadone
- methotrexate
- metrizamide
- mipomersen
- mixed respiratory vaccine
- monomethyl fumarate
- moxifloxacin
- mumps skin test antigen
- mumps virus vaccine
N
O
P
- palifermin
- pegaspargase
- pegfilgrastim
- peginterferon beta-1a
- pembrolizumab
- pertussis, acellular
- pexidartinib
- phenytoin
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- polyethylene glycol 3350 with electrolytes
- ponesimod
Q
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- remdesivir
- retifanlimab
- rifampin
- rilonacept
- ritlecitinib
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib topical
S
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- siponimod
- sipuleucel-T
- sirolimus
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium phosphate p32
- sparfloxacin
- staphage lysate (spl)
- streptococcus salivarius
- strontium-89 chloride
T
- tacrolimus
- talimogene laherparepvec
- tbo-filgrastim
- temsirolimus
- teriflunomide
- tetanus toxoid
- thalidomide
- theophylline
- thioguanine
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tislelizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tramadol
- tremelimumab
- trichophyton skin test
- trovafloxacin
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- valganciclovir
- valoctocogene roxaparvovec
- varicella virus vaccine
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vitamin e
- voclosporin
W
Y
Z
- zidovudine
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- zoster vaccine live
- zoster vaccine, recombinant
Blinatumomab disease interactions
There are 8 disease interactions with blinatumomab which include:
- vaccination
- leukoencephalopathy
- liver dysfunction
- metabolic acidosis
- neurologic disorders
- neutropenia
- pancreatitis
- renal impairment
More about blinatumomab
- blinatumomab consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.